Claim Ownership

Author:

Subscribed: 0Played: 0
Share

Description

 Episodes
Reverse
ISSCR 2022: Day 4

ISSCR 2022: Day 4

2022-06-1938:39

In June 2022, we attended the International Society for Stem Cell Research (ISSCR) annual meeting in San Francisco, and recorded daily episodes discussing highlights of the previous 24 hours. Here is the final of four special episodes from the meeting.
ISSCR 2022: Day 3

ISSCR 2022: Day 3

2022-06-1828:24

In June 2022, we attended the International Society for Stem Cell Research (ISSCR) annual meeting in San Francisco, and recorded daily episodes discussing highlights of the previous 24 hours. Here is the third of four special episodes from the meeting.
ISSCR 2022: Day 2

ISSCR 2022: Day 2

2022-06-1726:30

In June 2022, we attended the International Society for Stem Cell Research (ISSCR) annual meeting in San Francisco, and recorded daily episodes discussing highlights of the previous 24 hours. Here is the second of four special episodes from the meeting.
ISSCR 2022: Day 1

ISSCR 2022: Day 1

2022-06-1638:231

In June 2022, we attended the International Society for Stem Cell Research (ISSCR) annual meeting in San Francisco, and recorded daily episodes discussing highlights of the previous 24 hours. Here is the first of four special episodes from the meeting.
Dr. Michael Levin is the Director of the Allen Discovery Center and a Distinguished Professor of Biology at Tufts University. He is a cognitive biologist who utilizes model systems such as Xenopus to answer fundamental questions in developmental biology. He talks about regenerating frog legs, using bioelectricity to direct development, and the potential applications of xenobots.
Dr. Steven Stice is the DW Brooks Distinguished Professor and Director of the Regenerative Bioscience Center at the University of Georgia, and the Co-Founder and Chief Scientific Officer of ArunA Biomedical. He talks about his early work cloning rabbits and reprogramming blastomeres. He also discusses using exosomes to treat neurological diseases, helping trainees move into industry, and preserving endangered species.
Dr. Amritha Jaishankar is the Executive Director of the Maryland Stem Cell Research Fund (MSCRF). She is a scientist by training who has devoted her career to developing cures for debilitating and life-threatening conditions of our time and to advancing this field, through various roles in federal, university, and industry settings. She talks about the history of the MSCRF, its programs to promote the commercialization of stem cell-based technologies, and its role in the Maryland stem cell research ecosystem.
Dr. Ophir Klein is the inaugural Executive Director of Cedars-Sinai Guerin Children's and the David and Meredith Kaplan Distinguished Chair in Children's Health. He discusses his work on intestinal epithelium regeneration, which he will present at the “Tissue Fibrosis and Repair: Mechanism, Human Disease, and Therapies” Keystone Symposium taking place from June 12-16th in Keystone, Colorado. He also talks about mechanisms of tooth development, analyzing three-dimensional facial images to diagnose genetic syndromes, and how parasitic infections affect the intestinal stem cell niche.
Dr. David Hay is the Chair of Tissue Engineering at the University of Edinburgh, where his group is defining novel ways to produce liver tissue from PSCs. They use in vitro derived tissue to better model human liver physiology and to develop supportive cell based therapies for disease. Dr. Hay also founded Stimuliver, a company that is developing a disruptive liver implant to treat critically failing liver function in humans. He talks about hepatocyte differentiation, liver disease modeling, and automating the production of cell therapies.
Dr. Agnete Kirkeby is an Associate Professor at the University of Copenhagen and a Group Leader at Lund University. The Kirkeby group studies the factors involved in human neural subtype specification in order to enable production of specific neurons for understanding and treating neurological diseases. They apply advanced human stem cells models to understand how hundreds of human neuronal subtypes are formed during embryo development. She talks about moving stem cell therapies for Parkinson's disease from animal models to clinical trials, modeling neural tube development, and developing treatments for narcolepsy.
Dr. Melissa Little is the President, Keith Alm is the CEO, and Dr. Amander Clark is the Vice President of the International Society for Stem Cell Research (ISSCR). They discuss what they're looking forward to at the upcoming ISSCR 2022 meeting, and the future of the organization and the stem cell research community.
Dr. Kelly McNagny is a Professor of Medical Genetics and Biomedical Engineering at the University of British Columbia. His research program is focused on hematopoietic stem cell biology, specifically in understanding the signaling networks that regulate stem cell differentiation and how these cells interact with their microenvironment. He talks about how hematopoietic stem cell differentiation is related to chronic inflammatory disorders, targeting glycosylation in solid tumors, and his international career path.
Dr. Mingxia Gu is an Assistant Professor of Pediatrics at Cincinnati Children's Hospital. Her lab's goal is to develop novel therapies for the regeneration of the heart, lung, and vasculature in patients with congenital cardiac and pulmonary defects. She talks about developing lung organoids to study COVID-19, how multi-lineage organoids can mimic human tissues, and her lab's motto to "move fast and break things."
Dr. Alejo Rodriguez-Fraticelli is a Group Leader at the Institute for Research in Biomedicine in Barcelona, where his team studies stem cell memory and epigenetics in hematopoiesis, immunity, and leukemia. He talks about setting up a new lab as a "playground for scientists," how cancer is the "evil twin" of regeneration, and advanced methods for lineage tracing.
Dr. Nazish Sayed is an Assistant Professor of Surgery at the Stanford Cardiovascular Institute. His lab is focused on developing new technologies that drive innovation in regenerative medicine, disease modeling, and drug testing in vascular biology. He talks about developing an inflammatory aging clock, using iPSC-derived endothelial cells to run a clinical trial in a dish, and his experience as a cancer patient.
Dr. Ru Gunawardane is the Executive Director at the Allen Institute for Cell Science. She leads a group of researchers creating a collection of high-quality gene edited stem cell lines to study cell organization and activities through live cell imaging. Dr. Katylyn Gerbin is a Scientist at the Allen Institute, whose work focuses on implementing cardiac differentiation methods and developing the cardiomyocyte pipeline using gene-edited hiPSCs. They discuss the Institute's mission to understand the fundamentals of how cells work, how they generate their gene-edited stem cell lines, and their recent work tracking cell states in hiPSC-derived cardiomyocytes.
Dr. Ilyas Singeç is the Director of the Stem Cell Translation Laboratory at the National Center for Advancing Translational Sciences, where he leads a group of scientists working to address efficiency, reproducibility, scalability, and other roadblocks in the translation of iPSCs into therapies. He discusses the standardization of stem cell differentiation, high-throughput cell culture, personalized medicine, and the potential for biomanufacturing in space.
Dr. Sara Wickström is the Sigrid Juselius Professor of Cell and Developmental Biology at the University of Helsinki, and was recently appointed as the new Director of Cell and Tissue Dynamics at the Max Planck Institute for Molecular Biomedicine. Her research focuses on how mechanical forces act in collaboration with cellular signals to influence cell fate and position. She discusses her work on mechanotransduction and its applications for cell culture and organ engineering, as well as her research on the hair follicle stem cell niche. She also talks about running an interdisciplinary lab, and what could make academia a more attractive career path.
Dr. Christine Mummery is a Professor of Developmental Biology at the Leiden University Medical Center and the former President of the International Society for Stem Cell Research. She pioneered studies on cardiomyocytes from human embryonic stem cells and was among the first to inject them in mouse hearts after myocardial infarction. She talks about her recent research developing multi-lineage cardiac model systems like microtissues and organ-chips.
Dr. Kate Rubins is a NASA astronaut and microbiologist. She has completed two expeditions to the International Space Station and spent 300 days in space. She became the first person to sequence DNA in space in 2016, and grew cardiomyocytes in cell culture (in collaboration with Arun in Joseph Wu’s lab at Stanford) while in orbit.  She has a PhD in Cancer Biology from Stanford University and studied viral diseases as a Fellow/Principal Investigator at the Whitehead Institute.
Comments (3)

Bita Sedaghati

Proud of you Leili👍🏻

Sep 8th
Reply

Sergio Viafara

greeting from Colombia

Jan 25th
Reply (1)
Download from Google Play
Download from App Store